Medicare Enrolled
Dr. William McManus, M.D.
Interventional Cardiology · Stuart, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McManus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McManus? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McManus
Dr. William McManus is an interventional cardiology in Stuart, FL, with 19 years in practice. Based on federal Medicare data, Dr. McManus performed 12,307 Medicare services across 7,593 unique beneficiaries.
Between the years covered by Open Payments, Dr. McManus received a total of $8,765 from 41 pharmaceutical and/or device companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McManus is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 5% volume in FL$ $8,765 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,307
Medicare services
Top 5% in FL for interventional cardiology
7,593
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~648 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,693 | $96 | $225 |
| Electrocardiogram (EKG), 12-lead | 1,276 | $11 | $65 |
| Chronic care management, first 20 min/month | 1,226 | $52 | $130 |
| Regadenoson injection (Lexiscan) for heart stress test | 1,103 | $42 | $66 |
| Anticoagulant management of patient taking warfarin | 810 | $9 | $25 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 806 | $90 | $236 |
| Hospital follow-up visit, moderate complexity | 622 | $66 | $150 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 407 | $51 | $325 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 405 | $352 | $1,000 |
| Initial hospital admission, moderate complexity | 358 | $109 | $290 |
| Echocardiogram, transthoracic | 300 | $152 | $575 |
| Remote pacemaker/defibrillator monitoring, 90 days | 214 | $16 | $54 |
| Office visit, established patient (20-29 min) | 181 | $70 | $150 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 160 | $11 | $26 |
| Remote pacemaker monitoring, 90 days | 150 | $22 | $67 |
| New patient office visit (45-59 min) | 119 | $126 | $350 |
| Initial hospital admission, high complexity | 110 | $144 | $430 |
| Programming of dual lead pacemaker system | 96 | $58 | $150 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 95 | $20 | $60 |
| Chronic care management, additional 20 min/month | 90 | $39 | $97 |
| Cardiac catheterization | 84 | $227 | $710 |
| External shock to heart to regulate heart beat | 79 | $89 | $262 |
| Ultrasound of both sides of head and neck blood flow | 71 | $151 | $550 |
| Ultrasound of heart with probe in esophagus, with report | 65 | $86 | $459 |
| Hospital follow-up visit, high complexity | 65 | $99 | $220 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 64 | $28 | $102 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 60 | $17 | $69 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 45 | $48 | $285 |
| Hospital follow-up visit, low complexity | 45 | $40 | $80 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 36 | $28 | $104 |
| Office visit, established patient, complex (40-54 min) | 34 | $131 | $300 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 32 | $298 | $900 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 30 | $203 | $580 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 29 | $174 | $500 |
| Coronary stent placement | 28 | $482 | $1,400 |
| Injection, aminophyllin, up to 250 mg | 28 | $2 | $2 |
| Programming of dual lead implantable defibrillator system | 27 | $73 | $150 |
| Programming of single lead pacemaker system | 26 | $47 | $115 |
| Ultrasound of heart, follow-up | 26 | $20 | $85 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 22 | $40 | $110 |
| Programming of multiple lead implantable defibrillator system | 20 | $73 | $160 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 19 | $63 | $240 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $21 | $70 |
| Insertion of heart rhythm monitor under skin | 15 | $76 | $540 |
| 3d ultrasound imaging of heart for evaluation of heart structure performed during ultrasound imaging of congenital heart defects | 15 | $20 | $357 |
| Hospital discharge day management, 30 minutes or less | 15 | $67 | $155 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $19 | $170 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $17 | $121 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 13 | $11 | $103 |
| Ultrasound of heart blood flow, valves and chambers | 13 | $41 | $185 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 13 | $187 | $595 |
| Replacement of aortic valve through the skin and femoral artery | 12 | $669 | $3,000 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 12 | $271 | $800 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.8% high complexity
18.7% medium
72.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,765
Total received (2018-2024)
Avg $1,252/year across 7 years
Top 49% in FL for interventional cardiology
41
Companies
528
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,765 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$962
2023$2,494
2022$1,066
2021$1,132
2020$627
2019$1,394
2018$1,090
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$1,087
E.R. Squibb & Sons, L.L.C.
$1,003
Medical Device Business Services, Inc.
$994
Novartis Pharmaceuticals Corporation
$706
PFIZER INC.
$703
AstraZeneca Pharmaceuticals LP
$435
Abbott Laboratories
$384
SANOFI-AVENTIS U.S. LLC
$366
Boston Scientific Corporation
$366
Amgen Inc.
$276
Biosense Webster, Inc.
$251
Boehringer Ingelheim Pharmaceuticals, Inc.
$239
Cardiovascular Systems Inc.
$237
Amarin Pharma Inc.
$212
United Therapeutics Corporation
$140
EKOS Corporation
$119
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$118
Esperion Therapeutics, Inc.
$115
Merck Sharp & Dohme LLC
$108
Edwards Lifesciences Corporation
$89
Lundbeck LLC
$82
Chiesi USA, Inc.
$81
Bayer Healthcare Pharmaceuticals Inc.
$76
Bayer HealthCare Pharmaceuticals Inc.
$65
Novo Nordisk Inc
$56
Medtronic, Inc.
$48
ABIOMED
$48
Medtronic Vascular, Inc.
$45
Regeneron Healthcare Solutions, Inc.
$44
Lexicon Pharmaceuticals, Inc.
$38
Alnylam Pharmaceuticals Inc.
$34
Kowa Pharmaceuticals America, Inc.
$34
Cardinal Health 200, LLC
$28
Actelion Pharmaceuticals US, Inc.
$22
iRhythm Technologies, Inc.
$18
AGEPHA Pharma FZ LLC
$18
ShockWave Medical, Inc
$18
SCPHARMACEUTICALS INC.
$17
CVRx, Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$15
Bardy Diagnostics, Inc.
$12
Top 3 companies account for 35.2% of total payments
Associated products mentioned in payments ›
AMPLATZER AMULET · Arcalyst · BRILINTA · Barostim Neo System · BodyGuardian · CAMZYOS · CARTO 3 · CHANTIX · CLEVIPREX · Carnation Ambulatory Monitor · Corlanor · Coronary Orbital Atherectomy System · EKOSONIC · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FUROSCIX · HeartMate 3 Left Ventricular Dev · Impella · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LINQ II · LODOCO · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MULTAQ · MitraClip System · NA · NEXLETOL · NORTHERA · NUVISION ICE CATHETER · ONPATTRO · OPSUMIT · Optis Coronary Imaging System · Ozempic · PRADAXA · PRALUENT · REVEAL LINQ · Repatha · Reveal LINQ · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Soundstar · TYVASO · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $71 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
6
Per 100K population
3.7
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. McManus is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 5% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. McManus experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. McManus performed 2,693 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McManus receive payments from pharmaceutical companies?
Yes. Dr. McManus received a total of $8,765 from 41 companies across 528 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McManus's costs compare to other interventional cardiologys in Stuart?
Dr. McManus's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McManus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Stuart
Browse interventional cardiologys in Stuart ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in FL
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in FL
Which FL interventional cardiologys receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Medical Device Business Services, Inc. Payments to Doctors
See all physicians who received payments from Medical Device Business Services, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology